A bionic revolution is brewing, as recent advancements in bioengineering have brought about scientific breakthroughs in rehabilitation for people with disabilities. The most cutting edge research is happening inside the human brain, where implanted technology allows people to communicate directly with computers, using their thoughts.
VICE’s Wilbert L. Cooper travels to Zurich to see the first-ever bionic Olympics and discovers a host of technologies that are expanding what it means to be human.
Four years ago, Todd Rider was on top of the world. The MIT-trained bioengineer had developed a radical idea for killing viruses. Initial test results showed that his therapy, called DRACO, could kill every virus he threw it at: 15 viruses were killed in human cells, and two in mice.
Gene editing holds promise for the treatment of cancers that are driven by well-characterised molecular alterations. A study now provides a proof of concept for the feasibility of in vivo gene editing to correct TERT mutations in glioblastoma, providing a platform for the direct manipulation of genetic alterations to reduce tumour growth.
It is in this second phase when Darwinian evolutionary rivers will merge with the rivers of intelligent designers, represented by scientists, programmers and engineers, who will fuse organic natural biology, synthetic biology, and digital technology into a unified whole that future generations will deem their anatomy. The merger will serve to afford greater intelligence and, longer, healthier lives. In exchange, we will relinquish actual autonomy for apparent autonomy, where what was once considered “free will” will be supplanted by the deterministic logic of machinery somewhere in the mainstream of our unconscious.
Although in-the-body technology will have an explosive effect on commerce, entertainment, and employment, in the near term the concentration will be on medical devices, such as the innocuous pacemaker (essentially a working silicon-based computer, with sensors, memories, and a stimulation device with telecommunications to the outer world). In a second epoch, these devices will be gradually down-sized by advances in synthetic DNA, molecular- and nano-sized processors, each deployed alongside and within cells and organs as permanent non-organic, internal adjuncts to our anatomy for use as: nano-prosthetics, nano-stimulators/suppressors, artificial organ processors, metabolic and cognitive enhancers, and permanent diagnostic tools to ensure our physical and psychological well-being as we head toward a practically interminable lifetime.[6]
If there is a discernible duty here it is surely to create the best possible child. That is what it is to act for the best, all things considered. This we have moral reasons to do; but they are not necessarily overriding reasons.
In October 2019, Liu and his colleagues published a paper in Nature, describing an even newer technology, called prime editing. Prime editing can not only make all twelve of the possible base substitutions, it can also make multiple-base insertions or deletions, without requiring a double-strand break. It achieves this with a multi-step operation that first cuts one strand, then performs the appropriate substitution, insertion, or deletion, and then nicks the second strand to allow the bases on the second strand to be replaced by bases that complement the ones substituted, inserted into or deleted from the first strand. The result is a modified stretch of DNA that had never been completely separated. This has the effect of massively reducing the number of off-target modifications.
This new prime editing variant of CRISPR technology, can make the same corrections to the defects that cause sickle cell disease and beta-thalassemia that standard CRISPR/Cas9 has now made in human subjects, but with less opportunity for unwanted off-target changes. Furthermore, its possible applicability is much wider. The ClinVar database lists over 75,000 pathogenic mutations in the human genome. Of these, over 89% are potentially correctable by prime editing.
Microsoft co-founder Bill Gates has been working to improve the state of global health through his nonprofit foundation for 20 years, and today he told the nation’s premier scientific gathering that advances in artificial intelligence and gene editing could accelerate those improvements exponentially in the years ahead.
“We have an opportunity with the advance of tools like artificial intelligence and gene-based editing technologies to build this new generation of health solutions so that they are available to everyone on the planet. And I’m very excited about this,” Gates said in Seattle during a keynote address at the annual meeting of the American Association for the Advancement of Science.
Dr. Theodore Ho talks about the rapidly expanding possibilities of stem cells to be used in reversing or slowing the aging process. He discusses his previous and current work with the brain, including such methods as tissue clearing, multifiber photometry and optogenetics, and single resolution calcium imaging and control. Dr. Ho is a neuroscientist and stem cell biologist studying the mechanisms and causes of biological aging and potential strategies to slow or reverse them, in order to prevent the onset of age
Associated diseases to help us live healthier and longer lives.
The generation of a chemical system capable of replication and evolution is a key objective of synthetic biology. This could be achieved by in vitro reconstitution of a minimal self-sustaining central dogma consisting of DNA replication, transcription and translation. Here, we present an in vitro translation system, which enables self-encoded replication and expression of large DNA genomes under well-defined, cell-free conditions. In particular, we demonstrate self-replication of a multipartite genome of more than 116 kb encompassing the full set of Escherichia coli translation factors, all three ribosomal RNAs, an energy regeneration system, as well as RNA and DNA polymerases. Parallel to DNA replication, our system enables synthesis of at least 30 encoded translation factors, half of which are expressed in amounts equal to or greater than their respective input levels. Our optimized cell-free expression platform could provide a chassis for the generation of a partially self-replicating in vitro translation system.